Literature DB >> 24814131

Rejoinder.

S Shamanna Iyengar1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24814131      PMCID： PMC4017386          DOI： 10.1016/j.ihj.2014.02.013

Source DB:  PubMed          Journal:  Indian Heart J        ISSN： 0019-4832


× No keyword cloud information.
  4 in total

1.  Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.

Authors:  S S Iyengar; T Nair; J S Hiremath; U Jadhav; V K Katyal; D Kumbla; I Sathyamurthy; R K Jain; M Srinivasan
Journal:  Indian Heart J       Date:  2013-07-10

2.  Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.

Authors:  Alan G Fraser; Jean-Claude Daubert; Frans Van de Werf; N A Mark Estes; Sidney C Smith; Mitchell W Krucoff; Panos E Vardas; Michel Komajda
Journal:  Eur Heart J       Date:  2011-05-14       Impact factor: 29.983

3.  Commentary: Use of registries to investigate the past and develop the future.

Authors:  Stefan James; Jean-Claude Daubert; Frans Van de Werf
Journal:  BMJ       Date:  2011-05-13

Review 4.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.